{"id":1385256,"title":"DSEN Abstract: Ondansetron use during pregnancy: Utilization and adverse outcomes - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-24","captureTimestamp":"2026-03-24T04:26:30.768000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53882.html?wbdisable=false","snippet":"DSEN Abstract Ondansetron use during pregnancy: Utilization and adverse outcomes (Q16-08) A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) In this large study of 4,103,695 pregnancies, ondansetron use during pregnancy was not associated…","rawSnapshotUrl":"/api/snapshots/raw/1385256","browseUrl":"https://replay.healtharchive.ca/job-8/20260324042630/https://cihr-irsc.gc.ca/e/53882.html?wbdisable=false#ha_snapshot=1385256","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}